Companies

Arena Pharmaceuticals, Inc.

NASDAQ: ARNA
$99.99
▲ $0.00 (+0.00%) today
Markets closed · 1:20am ET

ARNA Coverage

Page 8
9:27am ET
Investing

Top Day Trader Alerts (GE, PALM, VVUS, OREX, ARNA, MNKD)

Here are Wednesday’s top day trader and active trader alerts with more detailed trading volume and price analysis in the links over at VSInvestor.com: General Electric Co. (NYSE:GE) is challenging post-crash highs…

Douglas A. McIntyre
8:36am ET
Health and Healthcare

Arena’s Real Issue: Drugs Vs. Gym & Behavior Modification (ARNA)

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) is getting shelled this morning.  The company released “positive study data” this morning on trials for its obesity treatment Lorcaserin.  But the real issue around the results…

Douglas A. McIntyre
4:39pm ET
Health and Healthcare

Arena Raising R&D Funds (ARNA)

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) has filed to sell up to 25 million shares of common stock in a public secondary offering.  Underwriters were not listed.  Arena is a clinical-stage biotech company…

Douglas A. McIntyre
2:59pm ET
Investing

The 52-Week Low Club (BRL)(TSO)(PLA)(SDBT)(HANS)(ARNA)

Barr Pharmaceuticals (BRL) Says business pace is falling off. Down to $37.40 from 52-week high of $58.38. Tesoro Corporation (TSO) Broker downgrade. Dips to $22.92 from 52-week high of $65.98. Playboy Enterprises…

Douglas A. McIntyre